GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels

Discussion in 'Off-Topic Discussions' started by Lerner, Apr 17, 2025.

Loading...
  1. Lerner

    Lerner Well-Known Member

    Sign in



    Don't

    [​IMG]

    New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
    YI-JIN YU
    Thu, April 17, 2025 at 6:47 AM PDT

    [​IMG]
    Scroll back up to restore default view.
    Generate Key Takeaways


    New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 diabetes as injectable GLP-1 drugs.

    Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.

    [​IMG]
    PHOTO: A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. (Darron Cummings/AP)
    A reduction of 1.6% in A1C levels, the measurement of average blood glucose over the course of three months, is significant for people with Type 2 diabetes, who tend to have higher blood sugar levels and need to manage those levels to avoid secondary problems, such as heart disease, kidney disease or vision loss, according to the Centers for Disease
     
  2. Xspect

    Xspect Member non grata

    Duh !!! its in the name
    GLP-1 = glucagon-like peptide-1 (GLP-1)
    GLP1 mimics the actions of glucagon, which helps regulate blood sugar and appetite.
     
  3. Lerner

    Lerner Well-Known Member

    It's an oral med, instead of injection.
    This is an oral med, vs current injections.
     

Share This Page